Cargando…

NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance

OBJECTIVE: Up to now, serial NETest measurements in individuals assessing the disease course of gastroenteropancreatic neuroendocrine tumors (GEPNETs) at long-term follow-up and treatment response were not studied. DESIGN: The study was a longitudinal validation study of serial NETest measurements –...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Treijen, Mark J C, Korse, Catharina M, Verbeek, Wieke H, Tesselaar, Margot E T, Valk, Gerlof D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513663/ https://www.ncbi.nlm.nih.gov/pubmed/35951312 http://dx.doi.org/10.1530/EC-22-0146

Ejemplares similares

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
por: van Treijen, Mark J. C., et al.
Publicado: (2018)

The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
por: Malczewska, Anna, et al.
Publicado: (2019)

NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging
por: Malczewska, Anna, et al.
Publicado: (2019)

Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival
por: Levy, Sonja, et al.
Publicado: (2020)

Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
por: Filosso, Pier Luigi, et al.
Publicado: (2020)

Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base
por: van Treijen, Mark J C, et al.
Publicado: (2018)

The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK
por: Malczewska, A., et al.
Publicado: (2020)

Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study
por: Levy, Sonja, et al.
Publicado: (2022)

Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours
por: Clement, Dominique S. V. M., et al.
Publicado: (2023)

Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade
por: Kooyker, Arthur I, et al.
Publicado: (2019)

Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2020)

NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis
por: Malczewska, Anna, et al.
Publicado: (2020)

Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma
por: Knappskog, Stian, et al.
Publicado: (2023)

A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
por: Oberg, Kjell, et al.
Publicado: (2016)

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
por: Ramage, John K, et al.
Publicado: (2011)

GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETs) - APPROACH TO DIAGNOSIS AND MANAGEMENT
por: Oladejo, A.O.
Publicado: (2009)

mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs)
por: Zanini, Sara, et al.
Publicado: (2020)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness
por: Barrea, Luigi, et al.
Publicado: (2018)

Gastroenteropancreatic Neuroendocrine Carcinomas: The NET G3 Subcategory Is a Reality
por: Fazio, Nicola, et al.
Publicado: (2017)

Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
por: Uri, Inbal, et al.
Publicado: (2018)

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy
por: Halfdanarson, Thorvardur R., et al.
Publicado: (2023)

MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
por: Northcott, Paul, et al.
Publicado: (2022)

First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial
por: Levy, Sonja, et al.
Publicado: (2022)

Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era
por: Kim, Seung Tae, et al.
Publicado: (2016)

Exploring the Epigenome in Gastroenteropancreatic Neuroendocrine Neoplasias
por: Sharma, Rohini, et al.
Publicado: (2021)

Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort
por: Lithgow, K., et al.
Publicado: (2021)

Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell Carcinoma
por: Ko, Josephine Mun Yee, et al.
Publicado: (2020)

The Role of Serial Liquid Biopsy in the Management of Metastatic Non-Small Cell Lung Cancer (NSCLC)
por: Sama, Srikar, et al.
Publicado: (2022)

Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy
por: Farncombe, Kirsten M., et al.
Publicado: (2023)

Clinical features of gastroenteropancreatic tumours
por: Gut, Paweł, et al.
Publicado: (2015)

Is There a Role for Biomarkers in Surveillance of Pancreatic Neuroendocrine Neoplasms in Von Hippel-Lindau Disease?
por: Naber, Myrthe R, et al.
Publicado: (2021)

Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure?
por: Eikenboom, Ellis L., et al.
Publicado: (2023)

Liquid biopsy? A recent breakthrough in noninvasive bladder cancer surveillance
por: Kang, Minyong, et al.
Publicado: (2016)

The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor
por: Chen, Yating, et al.
Publicado: (2017)

Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
por: Satyal, Uttam, et al.
Publicado: (2019)

Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study
por: Cho, Mee-Yon, et al.
Publicado: (2012)

Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism
por: Santos, A. P., et al.
Publicado: (2019)

The New Radiolabeled Peptide (99m)TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
por: Gherghe, Mirela, et al.
Publicado: (2022)

Advances in the treatment of gastroenteropancreatic neuroendocrine tumors
por: Kunz, Pamela L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_10fs0dj6il66v8ob9t78o484l9